Choose 1 option.
Cumulus Pharma requires that once a field sales rep finalizes and submits a visit report, it must become immutable and no further edits should be allowed.
Which configuration ensures this behavior?

• A. Disable the StagePathPermissionsHandler and set the Visit Status to "Closed."
• B. Enable the VisitAutoSaveHandler and check "Allow edits after submission."
• C. Enable the VisitLockHandler and uncheck "Unlock submitted visit" in the Admin Console.

Choose 1 option.
Cumulus Pharma wants to launch a new product, "Immunexis," and mandates that field sales reps must capture explicit opt-in consent from Healthcare Providers (HCPs) before sending any digital marketing materials. The following records are already configured in Agentforce Life Sciences:
Data Use Purpose record for "Immunexis Marketing"
Communication Subscription record named "Immunexis KOL Webinar Series"
Engagement Channel Type record for "Email"
When reps attempt to capture consent on their iPads, they can see the "Immunexis KOL Webinar Series" subscription, but they cannot select "Email" as a channel to capture the opt-in preference.
Which step resolves this issue so the rep can select "Email" for this subscription?

• A. Navigate to the Consent Administration tab in the Admin Console and check the box for "Allow Email Channel."
• B. Create a Communication Subscription Consent record for the user profile to activate the channel visibility.
• C. Create a Communication Subscription Channel Type junction record to link the Subscription to the Engagement Channel Type.

Choose 1 option.
An Agentforce Life Sciences Consultant needs to configure sample management rules. They must specify which types of Healthcare Organizations (HCOs) are eligible to receive samples and enforce that users must enter a batch number for every sample dropped.
Which subsection of Visit Settings should the consultant use for these configurations?

• A. Sample and Validation Settings
• B. Samples and Items Settings
• C. Product Detailing Settings

Choose 1 option.
An Agentforce Life Sciences Consultant is setting up sample limits for a controlled substance. Legal requires that, if a field sales rep attempts to disburse more than the allowed quantity, the system must strictly prevent the transaction. The rep should receive a message and be unable to submit the visit until the quantity is corrected.
How should the consultant configure the Limit Enforcement Type on the Sample Limit Template?

• A. Set the Limit Enforcement Type to Error.
• B. Set the Limit Enforcement Type to Warning.
• C. Set the Limit Enforcement Type to Block.

Choose 1 option.
Cumulus Pharma requires field sales reps to collect product-specific communication preferences from Healthcare Providers (HCPs) during a visit.
Which configuration helps the reps manage and track consents for specific products?

• A. Use a custom lookup field in the Communication Subscription Consent object to associate Life Sciences Marketable Product.
• B. Create a Data Use Purpose record to associate a Life Sciences Marketable Product with a Communication Subscription record.
• C. Create a Life Sciences Marketable Product Consent record to associate a Life Sciences Marketable Product with a Contact Point Consent record.